Blood Pressure Status Modulates the Therapeutic Response to Sodium‐Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial

ABSTRACT Aims To evaluate the feasibility of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) as a systemic adjunct for patients with diabetic macular edema (DME) and hypertension. Materials and Methods This study encompassed a post hoc analysis of the COMET Trial data, focusing on patients with D...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ryoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Takayuki Baba, Shuichi Yamamoto, Koutaro Yokote
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-12-01
Edice:	Journal of Diabetes
Témata:	anti‐vascular endothelial growth factor injection diabetic macular edema hypertension sodium‐glucose cotransporter 2 inhibitor
On-line přístup:	https://doi.org/10.1111/1753-0407.70184
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!